ORI
DXCM icon

Oak Ridge Investments’s DexCom DXCM Stock Holding History

Oak Ridge Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,219
Closed -$283K – 171
2024
Q3 		$283K Sell
4,219
-58,607
-93% -$4.81M 0.02% 147
2024
Q2 		$7.12M Buy
62,826
+2,684
+4% +$339K 0.68% 31
2024
Q1 		$8.34M Buy
60,142
+1,370
+2% +$172K 0.84% 25
2023
Q4 		$7.29M Buy
58,772
+16,076
+38% +$1.64M 0.84% 27
2023
Q3 		$3.98M Buy
42,696
+1,404
+3% +$158K 0.51% 61
2023
Q2 		$5.31M Sell
41,292
-337
-0.8% -$40.8K 0.65% 47
2023
Q1 		$4.84M Buy
41,629
+774
+2% +$86.6K 0.65% 53
2022
Q4 		$4.63M Buy
40,855
+30,883
+310% +$3.39M 0.69% 51
2022
Q3 		$803K Hold
9,972
– – 0.12% 133
2022
Q2 		$743K Hold
9,972
– – 0.11% 132
2022
Q1 		$1.27M Sell
9,972
-24
-0.2% -$2.63K 0.14% 118
2021
Q4 		$1.34M Sell
9,996
-584
-6% -$83.9K 0.11% 125
2021
Q3 		$1.45M Sell
10,580
-120
-1% -$15.1K 0.13% 124
2021
Q2 		$1.14M Buy
10,700
+144
+1% +$13.8K 0.1% 134
2021
Q1 		$948K Sell
10,556
-600
-5% -$56.3K 0.09% 136
2020
Q4 		$1.03M Sell
11,156
-292
-3% -$26.1K 0.09% 145
2020
Q3 		$1.18M Buy
11,448
+20
+0.2% +$2.09K 0.09% 127
2020
Q2 		$1.16M Sell
11,428
-104
-0.9% -$9.3K 0.1% 121
2020
Q1 		$776K Sell
11,532
-144
-1% -$8.96K 0.08% 128
2019
Q4 		$639K Sell
11,676
-904
-7% -$42.9K 0.05% 158
2019
Q3 		$469K Sell
12,580
-92
-0.7% -$3.57K 0.04% 164
2019
Q2 		$475K Sell
12,672
-25,004
-66% -$786K 0.03% 162
2019
Q1 		$1.12M Sell
37,676
-956
-2% -$33.6K 0.07% 139
2018
Q4 		$1.16M Sell
38,632
-1,156
-3% -$36.7K 0.08% 139
2018
Q3 		$1.42M Buy
+39,788
New +$1.23M 0.08% 134

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Oak Ridge Investments's DXCM Position: Q4 2024 in Review

Oak Ridge Investments sold out of DexCom (DXCM) in Q4 2024, closing a stake of 4,219 shares — an estimated $283K sold.

Oak Ridge Investments first reported a position in DXCM in Q3 2018 and held it in 25 quarters. The position peaked at $8.34M in Q1 2024. 952 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Oak Ridge Investments reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Oak Ridge Investments sold 4,219 DexCom shares in Q4 2024, an estimated $283K.
  • Oak Ridge Investments first reported a position in DexCom in Q3 2018 and held it in 25 quarters.
  • Oak Ridge Investments's DexCom position peaked at $8.34M in Q1 2024.
  • 952 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Oak Ridge Investments's 13F filing for Q4 2024, filed 15 Jan 2025.